Roche Holding | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 60.34B 1.83B 2024-12
Alcon AG USD 4.54B 395M 2024-12
Almirall EUR 351.76M 538K 2024-06
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.73B 2.29B 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 28.53B 518.3M 2024-12
Fresenius EUR 13.28B 1.81B 2024-12
Fresenius Medical Care EUR 9.76B 202.37M 2024-12
Galapagos EUR 7.79M 453K 2025-03
Genmab DKK 937M 41M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
GRIFOLS EUR 8.68B 155.99M 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Lonza CHF 4.24B 602M 2024-12
Merck EUR 6.37B 1.51B 2024-12
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Orion EUR 290.8M 6.4M 2025-03
Pfizer USD 57.4B 597M 2024-12
Philips EUR 7.11B 3M 2024-12
Recordati EUR 1.26B 87.43M 2024-09
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
UCB EUR 2.82B 166M 2024-12



Roche Holding Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.